chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a nurse referring to unspecified patients of unknown age and gender. The patients' medical history, concurrent condition and concomitant therapy were not provided. The patients were vaccinated with the following improperly stored doses of VARIVAX (dose and route unknown) for prophylaxis: on 30-JAN-2017, 1 doses with lot# M030138 and expiration date 15-JUN-2018, 2 doses with lot# M033214 and expiration date 13-JUL-2018; on 31-JAN-2017, 1 dose with lot# M033214 and expiration date 13-JUL-2018, 1 dose with M009764 with expiration date 23-FEB-2018; on 01-FEB-2017, 1 doses with lot# M030138 and expiration date 15-JUN-2018, 1 dose with lot# M033214 and expiration date 13-JUL-2018, 1 dose with M027344 with expiration date 01-JUN-2018; 02-FEB-2017, 4 doses with lot# M030138 and expiration date 15-JUN-2018; 03-FEB-2017, 2 dose with lot# M030138 and expiration date 15-JUN-2018, 1 dose with M009764 with expiration date 23-FEB-2018, 1 dose with lot#M027344 with expiration date 01-JUN-2018; on 06-FEB-2017, 2 dose with lot# M030138 and expiration date 15-JUN-2018; on 07-FEB-2017, 2 dose with lot# M030138 and expiration date 15-JUN-2018; on 09-FEB-2017, 3 dose with lot# M030138 and expiration date 15-JUN-2018; on 10-FEB-2017, 2 dose with lot# M030138 and expiration date 15-JUN-2018; on 13-FEB-2017, 1 dose with lot# M030138 and expiration date 15-JUN-2018; on 14-FEB-2017, 1 dose with lot# M030138 and expiration date 15-JUN-2018, 2 dose with lot# M033214 and expiration date 13-JUL-2018; on 15-FEB-2017, 1 dose with lot# M033214 and expiration date 13-JUL-2018, 1 dose with lot#M030138 with expiration date 15-JUN-2018; on 16-FEB-2017, 2 dose with lot# M033214 and expiration date 13-JUL-2018; on 17-FEB-2017, 2 dose with lot#M033124 with expiration date 13-JUL-2018. The temperature excursions that VARIVAX experienced were as follows: lot# M030138 with expiration date 15-JUN-2018, lot# M033214 with expiration date 13-JUL-2018 and lot# M009764 with expiration date 23-FEB-2018, at -3 to 61 degrees Fahrenheit (F) for 27.5 hours on 28-JAN-2017 and at -11 to 48 degrees F for 4 hours on 17-FEB-2017. It was also reported that the vaccine also experienced the following temperature excursion previously: > 14 but < 46 degrees F (>-10 but < 8 degrees Centigrade (C)) for 23 hours 30 minutes; also: >46 but < 77 degrees F (>8 but < 25 degrees C) for 12 hours 45 minutes. This is one of two reports received from the same reporter. Additional information is not expected as there is no consent to contact the reporter. Sender's Comments: US-009507513-1702USA010259.
15Jan98 Pt recv 1 dose vax. 30Jan98 Pt devel over 50 lesions all over body & devel more at time of report.
She got the vaccine, everything was fine, they warned her about being sick.  She did not have any reaction at all until she woke up 13 days later on 3/5/2021 and her left eye was blind.  She had some sort of blob that changes colors and moves around.  It sometimes is orange.  She knew she did not have macular degeneration as it centers it.  Sometimes it sparkles and has grain to it.  He said that she had an arterial blood, and that leaked from the carotid artery into the eye has not completely sealed off.  She can see out of the right eye perfectly, but she cannot see a little out of the left eye.  If she's watching the TV she can see the top of the newscasters hair, but she cannot see anything below that.  Her vision is upward either, can see out of either side, but cannot below horizontal down.  He told her that it was basically a stroke that didn't reach her brain and went to her eye.  He told her to return to see him (ophthalmologist) on 5/18/21 at 10:00 AM.  She also is to see her PCP on 5/20/21.
Paresthesia in left foot upon awakening the morning after receiving the vaccination. The symptom began to subside on day three following the vaccination. By day four the symptom lessened to tingling in the toes of the left foot. By mid day on the fourth day the symptom had gone away.
3 weeks and 1 day after vaccine was administer I felt my eye burning put lubricated eye did not put my glaucoma drops on through out the day the eye  was burning and hurting  I went to the clinic and they said it was a broken blood vessel. It happen both times with both vaccines the same way. 48 -72 hours it lasted for both occasions.
Patient given injection of DTaP instead of TDaP with no adverse reation noted.  Vaccine not age appropriate.
This spontaneous report as received from a nurse refers to a 61 year old patient of unknown gender. There were none pertinent medical history and none drug reactions/allergies. On 02-JUL-2014 the patient was vaccinated with a dose of MMR II, 0.5 ml, subcutaneously. There were none concomitant medication. On approximately 12-JUL-2014, reported as about 10 days after the MMRI II injection the patient developed an injection site rash. The outcome of injection site rash was reported as recovered/resolved on 14-JUL-2014. There was no treatment given. There were no lab tests performed. The patient sought medical attention by contacting the nurse. The relatedness beween MMR II and adverse event was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
For about 72 hours I was experiencing bone pain, joint pain, and tingling with burning feeling under the skin. My bones and joints hurt so bad I could hardly walk and could hardly get out of bed. This included arms, legs, back, neck, hips. I felt like my skin was crawling from the inside out. I felt like my leg was going numb while trying to drive. Felt drained.
Vaccinated with the Smallpox "1st week in March" chest pn started 2 weeks later. Pt hospitalized hospital 22 Mar 08. Dx Myocarditis.  4/25/08 Reviewed hospital medical records for 3/29-3/31/2008. FINAL DX: none provided, no d/c summary available.  Cardiac consult states probable myocarditis secondary to smallpox vaccine. Records reveal patient experienced chest pain, EKG changes & troponin elevation at outlying ER. Patient had substernal chest pain & tightness x 4 days.    Transferred here for cardiac cath.
swelling, redness, heat, tenderness area of 4 1/2x4 1/2". Very tender in armpit area.
Information has been received from a certified medical assistant concerning a female patient who on 19-AUG-2009 experienced syncope after receiving a dose of GARDASIL. Unspecified medical attention had been sought. On 19-AUG-2009 the patient had recovered. Follow up information was received from a licensed practical nurse concerning the 20 year old female patient with no illness at the time of vaccination and no pre-existing allergies, birth defects or medical conditions who on 19-AUG-2009 at 11:36 was vaccinated with the first dose of GARDASIL on left arm (lot # 663452/0671Y). Patient passed out after injection was given. Patient stated "this happens all the time with injections". Patient did not eat before she came in for the vaccine. Patient was placed on the bed to lie down and then felt better. Additional information is not expected.
body aches; shoulder is really sore; some dizziness; felt nauseated; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), ARTHRALGIA (shoulder is really sore), DIZZINESS (some dizziness) and NAUSEA (felt nauseated) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for an unknown indication.     The patient's past medical history included No adverse event.   On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (body aches), ARTHRALGIA (shoulder is really sore), DIZZINESS (some dizziness) and NAUSEA (felt nauseated). At the time of the report, PAIN (body aches), ARTHRALGIA (shoulder is really sore), DIZZINESS (some dizziness) and NAUSEA (felt nauseated) outcome was unknown.            Reporter did not allow further contact
Parent reports fever of 101.3 and staring episode the day after vaccine, ?febrile seizure.
This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.   The nurse reported that, on 01-OCT-2016, the patient received an improperly stored VARIVAX (Lot #: M008171; Expiration date: 16-FEB-2018) for prophylaxis (Dose, route and anatomical location were not reported). No adverse effects reported.  Temperature/Time frame: >-15°C but <-10°C (>5°F but < 14°F) excursion reported for 46 hours 10 minutes (worst case) Previous temperature excursion:  >-15°C but <-10°C (>5°F but < 14°F) excursion reported for 133 hours and 30 minutes (worst case) The call was not because of a "data logger". There was no Product Quality Complaint (PQC) involved. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1701USA005376:
Discoloration of the injection site 4-5 days following injection. Itching, redness, and swelling of the injection site that began 8 days following injection.
PATIENT CALLED ON 04/06/2021 REPORTING FATIGUE THAT EMERGED AFTER A WEEK FOLLOWING HIS COVID 19 VACCINE (JANSSEN). HE STILL FEELS FATIGUE AFTER 3 WEEKS OF HIS IMMUNIZATION
developed an episode of shingles in the same area as before / leg; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (experienced shingles on leg in August 2019).   On 5th August 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The patient had experienced shingles in her leg. The patient received the dose of Shingrix and later developed an episode of shingles in the same area as before. The episode was not an open rash situation. The reporter did not clarify when the patient started having the episode. The reporter consented to follow up. The reporter did not provide details of 1st dose because it was not administered as his pharmacy but agreed to follow up.
pt recv vax 2JAN97 & 16JAN97 2wk p/vax & 4 days p/last dose of erythromycin pt devel a rash on arms, legs, & ears which consisted of red papules 2-3mm in diameter;reporting MD dx Giaonitti-Crosti synd;
Itching on right forearm. BP 129/83 (pulse 80), O2 sat 98%.
pt recv vax 13OCT95 & exp mild itching in response to heat, exercise, or stress;dx cholinergic urticaria;MD has not made connection between this condition & Engerix_B; tx allergy med;sx cont;
pt recv vax & pt lowered head  & passed out;BP 90/50, P84 420PM, BP 80/60, P 80 425PM;pt returned to chair passed out again, BP 92/60,P 80 430PM; BP 90/60 P80 435PM;given soda to drink;advised to eat meal when returned home;
12/16/2022 10:00 AM tested positive on at home test.  Started getting Cold like symptoms, body aches, runny nose, slight fever, and coughing.  Went to an Urgent Care where I was tested again for COVID-19 with a rapid test, positive as well.  Doctor proscribed a bad tasting medication whose name can?t be remembered, and to treat symptomatically.  A couple of days after starting the medication, I started to feel better.  A few days after the 5 day course of medication I felt much better, but fatigue lingered for about 3 months.
Nausea, headache, fatigue, diarrhea, body aches. Lasted for 5 days. I had to miss work. I looked on website to see if this was a side effect, but none of these symptoms were listed. A couple of coworkers had the same symptoms with time frame
Initial report was received 19 September 2010 from a health care professional which consisted of a cluster of three patients which involved  a case of misuse. This case captures one patient, and the other two patient's have been captured in case numbers 2010-05569 and 2010-05570. A 27-year-old female patient had received a 0.1 mL intradermal left forearm injection of H1N1 (lot number unknown) at 12:00 pm on 28 September 2010 and 30 minutes later, the patient developed an itchy red lump on the injection site which measured 1.5 x 1.5 inches in size. The event did not require a doctor's visit. Outcome was reported as not recovered. No additional information was provided at the time of the report. Follow-up was received from a health care professional on 12 November 2010. The patient received an intradermal injection of H1N1, sanofi pasteur lot number UP076AA. The injection was intended to be a tuberculin (TB) test. The patient's symptoms lasted about a week and did not require a doctor's visit. The patient had no illness at the time of vaccination. The patient fully recovered on 08 October 2010. Documents held by sender: None.
Dose 2 was given before minimum interval. It was given 9 days after the first dose.
hive like rash occured evening p/getting DTP in patches on body shoulder-tummy-thigh-face; also associated w/consumption of chocolate; t100, fussiness;
"Breathing difficulty, fever, body aches, tongue swelling, vomit, blood was showing as secondary issue in the nasal airway area and upper throat areas."  "Some blood was being vomited due to light airway bleeding."  events happened 4 hours after vaccination.
Pt seen in Family Health Clinic for c/o progressive bilateral lower leg "burning" sensation rash with diffuse petechiae x 2 days. Also, c/o headaches. Afebrile.
2 hours after shot, throat began closing, tightness in chest, eyes swollen.  Went to dr, he drew blood to check for egg allergy.  He started her on Zyrtec.
A nurse reported the occurrence of injection site cellulitis in a 5-year-old female who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix). The pt's medical history, concurrent conditions and concurrent medications were unknown. On 07/19/2002 the pt received her 5th injection of Infanrix into the righth thigh (lot DTPA566A2; expiry, 02/11/2004). On the same date, she received an injection of inactivated poliomyelitis virus vaccine (IPOL; Aventis Pasteur) into the left thigh. On 07/20/2002 she developed limb swelling and redness at the site of Infanrix administration. She was seen by the physician, who made a diagnosis of injection site cellulitis and prescribed unspecified antibiotics. The injection site cellulitis resolved four to five days after immunization. The reporter stated that the injection site cellulitis was probably related to Infanrix administration.
Administered on 02/19/2023, The BUD for this vial was 02/18/2023
Injection site is inflammed, red and swollen (10cm X 14cm) around with erythema. Dx: cellulitis from DTAP.
10 days later developed facial weakness rash and dizziness consistant with Ramsay Hunt syndrome
Headaches, a tumor in my right arm has disappeared, Sluggish, and tiredness in body.
Strong dissociation right afterwards Migraine, fever, extreme injection site pain, and weak limbs/lightheadedness the morning after
This spontaneous report as received from a pharmacist refers to a patient of unknown age. Patient medical history and current condition was not reported. On 20-NOV-2014 the patient was vaccinated with expired ZOSTAVAX, of dose 0.65 ml via subcutaneous route (frequency reported as once). Expiration date for the ZOSTAVAX was repotted as JULY-2014. No adverse events were reported. The outcome of the events was unknown. This is one of the several reports received from the same reporter. Additional information has been requested.
Approx 30 minutes after receiving Injectable H1N1 student returned to imms area stating , "I feel funny, heaviness in my chest, difficult to take a deep breath, naseated." 92/62 p 92 reg., r. 12 shallow, pale, skin warm, dry.  " My heart feels like it's taking off and then it slows down"  Complained of dizziness.  Able to sit up right in chair.  Juice and crackers given, complains of feeling "spacey" alert and oriented Mother notified to come to school.  Student monitored X 50 minutes, "did not feel better, did not feel worse". Ambulated with minimal assistance discharged to parent.  Advised to ER if increase symptoms.
Within 6 hours of the injection, chills and shivering, sweats, general weakness and inability to stand.  Stayed in bed for the entire day after the injection.
Suffered 2 major/large strokes in her occipital lobes and small  temporal stroke   She is now blind, unable to walk, sit, stand, eat by herself, and has speech issues. She is needing full care at this time and unknown what future holds  She has been in ICU since 4/17 as we found her unconscious 4/17-she was down by herself tor over 24 hours
pain from my navel to my spine on my right side and it was extreme pain; pain from my navel to my spine on my right side and it was extreme pain; I had hurt my back; shingles; This is a spontaneous report from a contactable other healthcare professional (Patient). A 44-year-old male patient received first dose of bnt162b2 (BNT162B2, PFIZER-BIOTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on Apr2021 (age at the time of vaccination was not provided) as DOSE 1, SINGLE for covid-19 immunization. The medical history included HIV undetectable, allergies to peanuts, Spleen removed all from an unknown date and unknown if ongoing, ongoing immune suppressed (not told to the public and especially the immune suppressed). The patient concomitant medications were not reported. The patient previously took toradol for drug hypersensitivity. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and did not receive any other medications within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 Prior to vaccination. It was reported that on 04Apr2021, after the first shot he had pain from his navel to his spine on his right side and it was extreme pain so he went to the ER and he said that he had hurt his back. The days passed and he went to another doctor and they said you indeed have shingles well nothing appeared until after the second shot and then he was covered and shingles overnight and have been dealing with this since the first vaccine. The patient asked why was this not told to the public and especially the immune suppressed. He had his spleen removed if he had known all this, he would not have taken it. He wanted to ask you all did not do clinical trials on these types of people. He was very pissed off. Adverse event resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Therapeutic measures were taken as a result of events with acyclovir. The patient was not tested for COVID-19 Since the vaccination. The outcome for the events was reported as not resolved at the time of this report.  Information on the lot/batch number has been requested.  Follow-up (19Jul2021): This is a follow-up spontaneous report from a contactable other healthcare professional (patient). No new information was received.  Information regarding the lot/batch number has been requested.  Follow-up (23Aug2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Itchy rash at the site of injection. Hard and swollen.  Started on the 8th day after vaccine. Small rash on my shoulders.
No menstrual cycle since the vaccine. This is very unusual for my body and there are no other factors (chance of pregnancy or taking birth control pills, etc.)
Within days of vaccination (smallpox) Pt described constant headache, dysarthria, and incoordination. MRI c/w cerebritis-cerebellitis. Tx IV steroids, Acyclovir, TCN.  11/7/06 Received medical records from 1st hospital which reveal patient admitted 10/12/06 w/bifrontal HA & slurred speech following small pox vax 10/6/06.  Initial CT of brain was WNL.  Then developed left facial weakness & mild asymmetry of reflexes.  MRI then revealed T2 signal in right superior & mid frontal gyri.  Initial labs were WNL.  LP revealed WBC 245, 91% lymphs, protein 194, glucose 58.  Tx for presumptive meningoencephalitis & suspected post vax reaction, viral .  Tx w/steroids, antivirals & antibiotics IV.  Appeared stable x 2 days then abruptly developed worsening speech, ataxia & repeat MRI showed new bilateral cerebellar T2 hyperintensity.   Final/Transfer DX: probable post immunization reaction with meningoencephalitis initially focal & now with bilateral cerebellar involvement.  Transferred to second hospital on 10/18/06. 1/23/07 Received medical records from 2nd hospital which included: 1. Additional progress notes records from community hospital. 2. Medical records from clinic s/p release from second hospital which relate s/s to smallpox vac reaction.  Still had speech difficulty, slow gait, right hand tremors & intermittent vision difficulty.  Was receiving PT/OT/ST.  As of 12/11/06 2-4 more mo of rehab recommended before returning to active duty.  Still having trouble with balance & gait disturbance. Vax records included here reveal patient received FluMist & Smallpox on 9/29/06. 3. D/C summary from 2nd hospital for 10/19-10/25/06 admit as well as H&P. 4. VHC Summary: Patient received anthrax, smallpox, flumist, & Hep A&B in preparation for deployment.  Patient developed frontal HA approx 6 days after receipt of vax which grew progressively worse until awoke 10/12 with slurred speech, difficulty walking, blurred vision, & hand tremors.  Went to Troop Medical Center then to civilian ER & was admitted.  MRI of brain was positive for ill defined abnormal T2 hyperintense signal involving gray & white matter of right superior frontal & right middle frontal gyri with suggestion of cortical thickening.  Admitted 10/12/06-10/19/06 & then transferred to second hospital. FINAL DX: post vaccination cerebellitis. Follow-up: C/O worsening frontal headache behind his eyes for 3-5 days that was not ameliorated with TYLENOL. On 12 Oct 06 he developed slurred speech, difficulty focusing his eyes and unsteadiness in his gait. He was seen and sent to ER. He denied chest pains, fever, SOB, nausea, vomiting, arthralgias, myalgias or any symptoms of a URI. Headache, general Start: 10/06/2006 End: 10/13/2006. Comment: frontal, behind eyes and occipital. Symptom: Gait abnormality Start: 10/12/2006 Comment: trouble with coordination (jumping, running, walking back wards). Symptom: Cognitive deficiency Start: 10/12/2006 End: 10/22/2006. Comment: has trouble with word finding and slurred speech when tired. Symptom: Tremors Start: 10/12/2006 End: 10/22/2006 Comment: of hands.
Information was received 11-JUL-2017 via a phone call from a healthcare worker who reported that a 60 year old patient (gender not provided, only patient initials and age) was vaccinated on 11-JUL-2017 with improperly stored ZOSTAVAX (Lot number N010494, expiration 16-MAR-2018) that was reconstituted with properly stored Merck Diluent (Lot number and expiration date were unknown).  The ZOSTAVAX had been stored at 7 degrees Fahrenheit for 5 hours and 10 minutes. There had not been a previous temperature excursion. The report had been called in due to a data logger. No adverse effects were reported. No further information was provided.  Additional information was requested.
p/vax pt exp inj site swelling & redness; T100 plus for 2 days; body aches all over; h/a; upset stomach; fever lasted 24hr; other symptoms lasted sl longer;
Patient hospitalized within 6 weeks of receiving COVID vaccination. Patient only admitted for 5 hours.